Clinical Trials

Clinical Trial
  • Status: Recruiting
  • Phase: N/A
  • Intervention Type: Other
  • Participants: 20
  • Start Date: April 20, 2022
Umbilical Cord Blood Treatment for Refractory Immune Cytopenia: a Single-arm Prospective Study
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 22
  • Start Date: June 30, 2021
A Phase 2 Trial of Acalabrutinib for the Treatment of Relapsed/Refractory Autoimmune Hemolytic Anemia
Search for trials
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 1
  • Intervention Type: Drug
  • Participants: 18
  • Start Date: April 2021
An Open Label, Long Term, Safety and Tolerability Study of Patients With Cold Agglutinin Disease Previously Treated With BIVV020
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2
  • Intervention Type: Drug
  • Participants: 18
  • Start Date: May 1, 2020
A Phase II, Single-Center, Open-label Trial to Determine the Safety and Efficacy of Ibrutinib in Refractory/Relapsed Autoimmune Hemolytic
Clinical Trial
  • Status: Not yet recruiting
  • Phase: Phase 2/Phase 3
  • Intervention Type: Drug
  • Participants: 50
  • Start Date: April 1, 2020
Sirolimus Combined With All Trans Retinoic Acid for the Treatment of Auto-Immune Anemia
Clinical Trial
  • Status: Recruiting
  • Phase: Phase 2/Phase 3
  • Intervention Type: Drug
  • Participants: 105
  • Start Date: February 25, 2020
Efficacy and Safety of M281 in Adults With Warm Autoimmune Hemolytic Anemia: A Multicenter, Randomized, Double-blind, Placebo-controlled Study With a Long-term Open-label Extension
Clinical Trial
  • Status: Active, not recruiting
  • Phase: Phase 3
  • Intervention Type: Drug
  • Participants: 80
  • Start Date: October 30, 2019
A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia
Showing 1-12 of 25